pH-responsive Targeted nanoparticles release ERK-inhibitor in the hypoxic zone Sensitizes Gemcitabine in Mutant K-Ras-addicted Pancreatic Cancer

Debasmita Dutta(North Dakota State University), Sushanta K. Banerjee(Kansas City VA Medical Center)
Research Square
May 15, 2023
Cited by 1


Related Papers